Dysrhythmias and heart failure complicating acute myocardial infarction: An emergency medicine review.
Atrial Fibrillation
/ etiology
Bradycardia
/ drug therapy
Emergency Medicine
Heart Block
/ etiology
Heart Failure
/ etiology
Humans
Myocardial Infarction
/ complications
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Shock, Cardiogenic
/ complications
Tachycardia, Ventricular
/ etiology
Acute myocardial infarction
Atrial fibrillation
Bradycardia
Cardiogenic shock
Dysrhythmia
Heart block
Heart failure
Ventricular tachycardia
Journal
The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
17
03
2019
revised:
24
04
2019
accepted:
26
04
2019
pubmed:
8
5
2019
medline:
15
2
2020
entrez:
8
5
2019
Statut:
ppublish
Résumé
Patients with acute myocardial infarction (AMI) may suffer several complications after the acute event, including dysrhythmias and heart failure (HF). These complications place patients at risk for morbidity and mortality. This narrative review evaluates literature and guideline recommendations relevant to the acute emergency department (ED) management of AMI complicated by dysrhythmia or HF, with a focus on evidence-based considerations for ED interventions. Limited evidence exists for ED management of dysrhythmias in AMI due to relatively low prevalence and frequent exclusion of patients with active cardiac ischemia from clinical studies. Management decisions for bradycardia in the setting of AMI are determined by location of infarction, timing of the dysrhythmia, rhythm assessment, and hemodynamic status of the patient. Atrial fibrillation is common in the setting of AMI, and caution is warranted in acute rate control for rapid ventricular rate given the possibility of compensation for decreased ventricular function. Regular wide complex tachycardia in the setting of AMI should be managed as ventricular tachycardia with electrocardioversion in the majority of cases. Management directed towards HF from left ventricular dysfunction in AMI consists of noninvasive positive pressure ventilation, nitroglycerin therapy, and early cardiac catheterization. Norepinephrine is the first line vasopressor for patients with cardiogenic shock and hypoperfusion on clinical examination. Early involvement of a multi-disciplinary team is recommended when caring for patients in cardiogenic shock. This review discusses considerations of ED management of dysrhythmias and HF associated with AMI.
Identifiants
pubmed: 31060863
pii: S0735-6757(19)30272-4
doi: 10.1016/j.ajem.2019.04.047
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1554-1561Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Published by Elsevier Inc.